Comparison of Double-kissing Crush and Double-kissing Culotte Stenting

Sponsor
Istanbul Mehmet Akif Ersoy Educational and Training Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04789161
Collaborator
(none)
200
1
38
5.3

Study Details

Study Description

Brief Summary

True bifurcation lesions (TBLs) are not rare clinical conditions and may be associated with adverse cardiovascular outcomes due to their complex anatomy and the variety of interventional therapy. Although the provisional stenting is still effective in suitable lesions, double stent techniques can be required in selected patients. In previous studies, double kissing crush (DK-crush) stenting was revealed as superior to provisional stenting in TBL of left main coronary artery. Additionally, in recent studies, double kissing approach facilitates and highlights double kissing culotte (DK-culotte) stenting with lower stent malapposition compared to DK-crush stenting. However, to the best of our knowledge, there is no study about comparing DK-crush and DK-culotte stenting in TBLs. Our aim in this study is to compare DK-crush and DK-culotte stenting in patients with TBL.

Condition or Disease Intervention/Treatment Phase
  • Procedure: double kissing crush stenting
  • Procedure: double kissing culotte stenting

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Comparison of Double-kissing Crush and Double-kissing Culotte Stenting in Patients With True Bifurcation Lesion
Actual Study Start Date :
Mar 4, 2021
Anticipated Primary Completion Date :
Apr 4, 2023
Anticipated Study Completion Date :
May 4, 2024

Arms and Interventions

Arm Intervention/Treatment
double kissing crush stenting

patients with true bifurcation lesion undergoing double kissing crush stenting

Procedure: double kissing crush stenting
Patients with true bifurcation lesion treating with double kissing crsuh stenting technique

double kissing culotte stenting

patients with true bifurcation lesion undergoing double kissing culotte stenting

Procedure: double kissing culotte stenting
Patients with true bifurcation lesion treating with double kissing culotte stenting technique

Outcome Measures

Primary Outcome Measures

  1. MACE (major adverse cardiovascular events) [12 months]

    target vessel revascularization, myocardial infarction and cardiac death

Secondary Outcome Measures

  1. MACCEs (major adverse cerebral and cardiovascular events) [12, 24, 36 months]

    all cause death, myocardial infarction, target lesion revascularization, target lesion revascularization, in-stent thrombosis and/or restenosis, stroke

  2. target lesion failure [24, 36 months]

    myocardial infarction, cardiac death

Other Outcome Measures

  1. contrast induced nephropathy [12 months]

    25 percent (%) increase in serum creatinine level from baseline or a 0.5 mg/dL increase in absolute serum creatinine value within 72 hours after percutaneous coronary intervention

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with de novo true bifurcation lesion (Medina classification 1,1,1 or 0,1,1 or 1,0,1)

  • The main vessel diameter is least 2.5 mm and the side branch diameter is at least 2.25 mm

Exclusion Criteria:
  • Patients presenting with ST segment elevation myocardial infarction, cardiogenic shock and Killip class III-IV heart failure

  • Patients with a history of coronary artery bypass grafting surgery

  • Patients with a chronic total occlusion in the bifurcation area

  • Lesions with severe calcification that needs additional intervention such as atherectomy

  • Patients who are not suitable to use long term dual antiplatelet therapy and patients not participating in clinical follow-up

  • Patients with hematological disorders, malignancy, end stage renal (GFR<30 ml/min) and hepatic failure

  • Patients with active bleeding

  • Pregnant women

  • Patients with life-expectancy < 1 year

Contacts and Locations

Locations

Site City State Country Postal Code
1 Istanbul Mehmet Akif Ersoy Training and Research Hospital Istanbul Turkey 34303

Sponsors and Collaborators

  • Istanbul Mehmet Akif Ersoy Educational and Training Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Serkan Kahraman, Associate Professor, Istanbul Mehmet Akif Ersoy Educational and Training Hospital
ClinicalTrials.gov Identifier:
NCT04789161
Other Study ID Numbers:
  • IMAEETH-2
First Posted:
Mar 9, 2021
Last Update Posted:
Mar 29, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 29, 2022